aspirin has been researched along with fluorouracil in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (16.67) | 18.7374 |
1990's | 2 (4.17) | 18.2507 |
2000's | 17 (35.42) | 29.6817 |
2010's | 16 (33.33) | 24.3611 |
2020's | 5 (10.42) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gust, R; Kircher, B; Ott, I; Schmidt, K; Schumacher, P; Wiglenda, T | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Gust, R; Huang, W; Liu, W; Qian, H; Zhang, H; Zhang, T; Zhou, J; Zhu, H | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Amin, S; Karelia, DN; Pandey, MK; Plano, D; Sharma, AK; Spallholz, JE | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, Y; Liu, L; Nie, X; Shi, D; Wang, J; Wang, Y; Wei, G; Zhang, L; Zheng, C | 1 |
Ai, Y; Lu, S; Obianom, ON | 2 |
Ding, F; Gao, Y; Guo, Y; He, X; Li, S; Li, X; Liu, Z; Nie, Y; Wen, D; Zhang, Y; Zhong, M | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Fukuzawa, Y; Isobe, M; Kishimoto, T; Okazaki, M; Tada, M | 1 |
Amblard, P; Bastrenta, F; Beani, JC; Gautron, R; Harrouch, L; Jardon, P; Reymond, JL | 1 |
Rieche, K; Wand, H | 1 |
Palasz, M | 1 |
Slezak, H | 1 |
Hirono, S; Ito, S | 1 |
Capel, ID; Cosier, RS; Pinnock, MH; Williams, DC | 1 |
Etienne, MC; Milano, G; Speziale, N | 1 |
Bours, V; Fillet, G; Jerusalem, G | 1 |
ROTH, JL | 1 |
Dzik-Jurasz, AS; Leach, MO; Rowland, IJ | 1 |
Ashktorab, H; Dawkins, FW; Larbi, D; Mohamed, R; Smoot, DT | 1 |
Chessin, DB; Guillem, JG; Katz, MS; Minsky, BD; Riedel, E; Saltz, LB | 1 |
Augustin, M; Cummerow, R; Hartmann, A; Schlöbe, A; Zschocke, I | 1 |
Amadori, D; Bolla, M; Cecconetto, L; Fabbri, F; Leonetti, C; Medri, L; Rosetti, M; Scarsella, M; Tesei, A; Ulivi, P; Zoli, W; Zupi, G | 1 |
Becker, PD; Camacho, EM; Cebolla, A; Guzmán, CA; Link, C; Royo, JL; Santero, E | 1 |
Finlay, BB; Gal-Mor, O | 1 |
Drew, PA; Jamieson, GG; Liu, JF; Wu, TC; Zhu, GJ | 1 |
Chan, AP; Chan, SK; Hasan, MR; Jin, C; Kim, J; Kim, YB; Le, ND; Rahman, M; Selvarajan, K; Tai, IT | 1 |
Jia, Q; Wang, Z; Wu, L; Zhang, W; Zhang, X; Zhang, Y | 1 |
Ali, R; Chan, ML; Chia, WK; Deng, YH; Ho, GF; Jian, X; Mehta, S; Segelov, E; Sharma, A; Soon, SS; Tan, CS; Toh, HC; Wee, HL | 1 |
Benson, AB; Chan, AT; Chan, JA; Fuchs, CS; Giovannucci, EL; Goldberg, RM; Hantel, A; Mayer, RJ; Meyerhardt, JA; Ng, K; Niedzwiecki, D; Ogino, S; Saltz, LB; Sato, K; Schaefer, PL; Venook, AP; Whittom, R | 1 |
Kmieć, Z; Olejniczak-Kęder, A; Siedlecka-Kroplewska, K; Szaryńska, M; Wrońska, A | 1 |
Fu, J; Liu, Y; Ma, L; Xu, Y; Yang, Y; Zhang, Y | 1 |
Shen, Y; Wang, P; Zhao, L | 1 |
Abdullahi, A; Abubakar, S; Adamu, A; Adoke, KU; Aminu, SM; Awasum, CA; Faruk, M; Ibrahim, S; Idoko, J; Iliyasu, Y; Manko, M; Mohammed, A; Musa, HS; Ntekim, A; Rafindadi, AH; Randawa, AJ; Saidu, R; Shah, KZ; Suleiman, AM | 1 |
Dehelean, C; Ilia, I; Ionita, I; Macasoi, I; Pinzaru, I; Susan, M; Susan, R | 1 |
3 review(s) available for aspirin and fluorouracil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Effect of some drugs in the development and exacerbation of gastric and duodenal ulcer].
Topics: Adrenocorticotropic Hormone; Aspirin; Caffeine; Catecholamines; Duodenal Ulcer; Fluorouracil; Glucocorticoids; Histamine; Humans; Hypoglycemic Agents; Indomethacin; Parasympathomimetics; Phenylbutazone; Quinolines; Reserpine; Stomach Ulcer | 1974 |
[Efficacy and benefit of a 5-FU/salicylic acid preparation in the therapy of common and plantar warts--systematic literature review and meta-analysis].
Topics: Aspirin; Drug Combinations; Fluorouracil; Foot; Humans; Internationality; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome; Warts | 2004 |
1 trial(s) available for aspirin and fluorouracil
Article | Year |
---|---|
A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Squamous Cell; Cardia; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Stomach Neoplasms; Survival Analysis | 2009 |
44 other study(ies) available for aspirin and fluorouracil
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.
Topics: Alkynes; Antineoplastic Agents; Apoptosis; Aspirin; Cell Line, Tumor; Cell Nucleus; Cobalt; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Humans; Membrane Proteins; Organometallic Compounds; Prostaglandin-Endoperoxide Synthases | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Design and synthesis of thiourea derivatives containing a benzo[5,6]cyclohepta[1,2-b]pyridine moiety as potential antitumor and anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Biological Assay; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclization; Disease Models, Animal; Drug Design; Female; Humans; Inhibitory Concentration 50; Mice; Pyrimidines; Thiourea | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship | 2016 |
Synthesis and biological evaluation of novel podophyllotoxin-NSAIDs conjugates as multifunctional anti-MDR agents against resistant human hepatocellular carcinoma Bel-7402/5-FU cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship | 2017 |
Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
Topics: Acrolein; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship | 2018 |
Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer
Topics: | 2018 |
New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Effects of antipyretics and anticancer drug on human cells at high temperature condition].
Topics: Aspirin; Cells, Cultured; Dipyrone; Drug Evaluation, Preclinical; Endothelium, Vascular; Fetus; Fluorouracil; HeLa Cells; Humans; Lung; Temperature; Umbilical Veins | 1988 |
Screening for drug photosensitization activity by measuring the variations in oxygen consumption of Bacillus subtilis.
Topics: Aspirin; Bacillus subtilis; Benzoyl Peroxide; Chlorpromazine; Erythromycin; Fluorouracil; Light; Methoxsalen; Oxygen Consumption; Patch Tests; Photosensitivity Disorders; Tretinoin | 1985 |
Influence of cytostatics on aggregation and adenine nucleotides of platelets.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Amidines; Antineoplastic Agents; Aspirin; Bleomycin; Blood Platelets; Cell Membrane; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Glyoxal; Humans; Hydrazones; Methotrexate; Neoplasms; Platelet Adhesiveness; Triaziquone; Vinca Alkaloids | 1972 |
[Drug-induced eye lesions in the aged].
Topics: Aged; Antipsychotic Agents; Aspirin; Cataract; Conjunctival Diseases; Corneal Diseases; Eye Diseases; Fluorouracil; Glaucoma; Humans; Lacrimal Apparatus; Optic Nerve Diseases; Phenothiazines; Practolol; Retinal Diseases | 1983 |
[Two cases with microangiopathic hemolytic anemia caused by anti-cancer drugs who improved rapidly after administration of aspirin and dipyridamole].
Topics: Adult; Aged; Anemia, Hemolytic; Antineoplastic Agents; Aspirin; Chromomycin A3; Dipyridamole; Female; Fluorouracil; Humans; Male; Mitomycin; Mitomycins; Stomach Neoplasms | 1982 |
Use of inverted intestinal sacs to assess the effect of gastrointestinal insult on carcinogen absorption.
Topics: Animals; Aspirin; Benzopyrenes; Carcinogens; Cold Temperature; Dimethylnitrosamine; Dose-Response Relationship, Drug; Ethanol; Fluorouracil; Intestinal Absorption; Intestinal Diseases; Male; Rats; Stress, Physiological | 1981 |
HPLC of folinic acid diastereoisomers and 5-methyltetrahydrofolate in plasma.
Topics: Acetaminophen; Aspirin; Chromatography, High Pressure Liquid; Fluorouracil; Humans; Leucovorin; Quality Control; Stereoisomerism; Tetrahydrofolates | 1993 |
[How I treat colorectal cancer. I. Prevention and adjuvant treatment].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Belgium; Chemotherapy, Adjuvant; Colonic Neoplasms; Diet; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Rate | 1998 |
ROLE OF DRUGS IN PRODUCTION OF GASTRODUODENAL ULCER.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aspirin; Caffeine; Cats; Fluorouracil; Histamine; Humans; Pathology; Peptic Ulcer; Phenylbutazone; Quinolines; Research; Reserpine; Toxicology | 1964 |
Investigation of microenvironmental factors influencing the longitudinal relaxation times of drugs and other compounds.
Topics: Albumins; Aspirin; Contrast Media; Floxacillin; Fluorocarbons; Fluorouracil; Gadolinium DTPA; Magnetic Resonance Imaging; Phantoms, Imaging; Protein Binding; Succinates; Viscosity | 2004 |
Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Aspirin; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluorouracil; Humans; Proto-Oncogene Proteins c-bcl-2 | 2005 |
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Combined Modality Therapy; Female; Fluorouracil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neoadjuvant Therapy; Odds Ratio; Radiotherapy Dosage; Rectal Neoplasms; Retrospective Studies | 2005 |
Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Cell Survival; Colonic Neoplasms; Flow Cytometry; Fluorouracil; Humans; Male; Mice; Mice, Nude; Nitric Oxide; Nitro Compounds; Organoplatinum Compounds; Oxaliplatin; Transplantation, Heterologous | 2006 |
In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit.
Topics: 3-Phosphoshikimate 1-Carboxyvinyltransferase; Animals; Aspirin; Bacterial Proteins; beta-Galactosidase; Cell Line, Tumor; Flucytosine; Fluorouracil; Gene Expression; Gene Expression Regulation, Bacterial; Genetic Engineering; Green Fluorescent Proteins; HeLa Cells; Humans; Lac Operon; Macrophages; Mice; Neoplasms; Operon; Promoter Regions, Genetic; Salmonella enterica; Salmonella Infections; Sodium Salicylate; Spleen; Transcription Factors | 2007 |
Pathogens on aspirin: promising research and therapeutic applications.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Proteins; Flucytosine; Fluorouracil; Gene Expression Regulation, Bacterial; Mice; Neoplasms; Salmonella enterica; Salmonella Infections; Sodium Salicylate | 2007 |
Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Celecoxib; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Middle Aged; Pyrazoles; Sulfonamides; Xenograft Model Antitumor Assays | 2012 |
Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model.
Topics: Animals; Aspirin; Fluorouracil; Lymphangiogenesis; Lymphatic Vessels; Male; Mice; Neovascularization, Pathologic; Random Allocation; Sarcoma, Experimental; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor C; Xenograft Model Antitumor Assays | 2013 |
Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Aspirin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Humans; Markov Chains; Models, Economic; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Remission Induction; Reproducibility of Results; Secondary Prevention | 2014 |
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Camptothecin; Chemotherapy, Adjuvant; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Disease-Free Survival; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Prospective Studies; Sex Factors; Treatment Outcome | 2015 |
Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system of HCT116 and HT29 colorectal cancer cell lines.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Autophagy; Cell Cycle; Cell Survival; Colorectal Neoplasms; Cyclooxygenase 2; ErbB Receptors; Fas Ligand Protein; fas Receptor; Fluorouracil; HCT116 Cells; HT29 Cells; Humans; Spheroids, Cellular | 2019 |
Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Aspirin; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Fluorouracil; Humans; Mice; NF-kappa B; Xenograft Model Antitumor Assays | 2019 |
Chitosan nanoparticles loaded with aspirin and 5-fluororacil enable synergistic antitumour activity through the modulation of NF-κB/COX-2 signalling pathway.
Topics: Antineoplastic Agents; Aspirin; Chitosan; Cyclooxygenase 2; Drug Synergism; Fluorouracil; Hep G2 Cells; Humans; Nanoparticles; NF-kappa B; Signal Transduction | 2020 |
Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
Topics: Adaptor Proteins, Signal Transducing; Animals; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; B7-H1 Antigen; Biomarkers, Tumor; Cell Line, Tumor; Colorectal Neoplasms; DNA Mismatch Repair; Drug Interactions; Duffy Blood-Group System; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Leucovorin; Male; Mismatch Repair Endonuclease PMS2; MutS Homolog 2 Protein; Neoplasm Proteins; Organoplatinum Compounds; Prognosis; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, Cell Surface; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |
In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Aspirin; bcl-2-Associated X Protein; Caspases; Colorectal Neoplasms; Fluorouracil; Humans | 2023 |